Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2026-03-06 @ 6:14 PM
Study NCT ID:
NCT04689360
Status:
AVAILABLE
Last Update Posted:
2025-02-14
First Post:
2020-12-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Intermediate Size Expanded Access Protocol of Elamipretide
Sponsor:
Stealth BioTherapeutics Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPIES-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None